The Jaklenec Research Lab at the MIT Koch Institute for Integrative Cancer Research works at the interface of engineering and immunology with a focus on global health. The lab develops innovative and translatable technologies to help large populations globally, especially in developing countries.
Recent News
Implantable Microparticles Can Deliver Two Cancer Therapies at Once
November 3, 2024
Patients with late-stage cancer often have to endure multiple rounds of different types of treatment, which can cause unwanted side effects and may not always help…
Cutting-edge microparticles can deliver two cancer treatments at once
November 2, 2024
New MIT dual-therapy microparticles deliver chemotherapy and heat, eliminating tumors in mice and potentially extending patient lifespan…
Implantable microparticles can deliver two cancer therapies at once
November 1, 2024
Researchers designed tiny particles that can be implanted at a cancer tumor site, where they deliver two types of therapy: heat and chemotherapy…